As shown in Figure 1A, the expression level of CDR1as was relatively higher in glioblastoma multiforme (GBM), neuroblastoma (NRBL), sarcoma (SARC), secretory cancer (SECR), breast cancer (BRCA), and melanoma (SKCM). Here, LINC00632 is linked to sarcoma.